




Searching News Database: bone metastases
HSMN NewsFeed - 18 Oct 2022
Dr. Brett King Joins BiologicsMD as Senior Scientific Advisor and Member of the Scientific Advisory Board
Dr. Brett King Joins BiologicsMD as Senior Scientific Advisor and Member of the Scientific Advisory Board
HSMN NewsFeed - 19 Feb 2019
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
HSMN NewsFeed - 10 Jul 2017
FDA Grants Priority Review for Lilly's Abemaciclib for the Treatment of Advanced Breast Cancer
FDA Grants Priority Review for Lilly's Abemaciclib for the Treatment of Advanced Breast Cancer
HSMN NewsFeed - 13 Jun 2013
FDA Approves Amgen's XGEVA(R) (denosumab) For The Treatment Of Giant Cell Tumor Of Bone
FDA Approves Amgen's XGEVA(R) (denosumab) For The Treatment Of Giant Cell Tumor Of Bone
HSMN NewsFeed - 26 Nov 2012
GE Healthcare Redefines Comfort, Confidence and Connectivity in Radiology at RSNA Conference
GE Healthcare Redefines Comfort, Confidence and Connectivity in Radiology at RSNA Conference
HSMN NewsFeed - 22 Oct 2012
FDA Approves New Non-Invasive, Non-Ionizing Radiation Therapy to Treat Pain from Bone Metastases
FDA Approves New Non-Invasive, Non-Ionizing Radiation Therapy to Treat Pain from Bone Metastases
HSMN NewsFeed - 15 Jul 2011
XGEVA(R) (Denosumab) Granted Marketing Authorization in the European Union
XGEVA(R) (Denosumab) Granted Marketing Authorization in the European Union
HSMN NewsFeed - 20 May 2011
Amgen Receives CHMP Positive Opinion for XGEVA (Denosumab) in the European Union
Amgen Receives CHMP Positive Opinion for XGEVA (Denosumab) in the European Union
HSMN NewsFeed - 13 Dec 2010
XGEVA (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
XGEVA (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
HSMN NewsFeed - 4 Oct 2010
DFine Announces FDA 510(k) Clearance of New Radiofrequency Ablation System for Metastatic Spinal Lesions
DFine Announces FDA 510(k) Clearance of New Radiofrequency Ablation System for Metastatic Spinal Lesions
HSMN NewsFeed - 29 Sep 2010
InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010
InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010
HSMN NewsFeed - 4 Jun 2010
Bayer Presents Clinical Data on Alpharadin in Metastatic Castration-Resistant Prostate Cancer (CRPC)
Bayer Presents Clinical Data on Alpharadin in Metastatic Castration-Resistant Prostate Cancer (CRPC)
HSMN NewsFeed - 19 Feb 2010
FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date
FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date
HSMN NewsFeed - 11 Dec 2008
New Data Shows Zometa(R) Enhances Impact of Chemotherapy on Reducing Breast Tumour Size
New Data Shows Zometa(R) Enhances Impact of Chemotherapy on Reducing Breast Tumour Size
HSMN NewsFeed - 25 Jul 2008
Amgen Announces Positive Top-Line Results for Denosumab Pivotal Postmenopausal Osteoporosis Trial
Amgen Announces Positive Top-Line Results for Denosumab Pivotal Postmenopausal Osteoporosis Trial
HSMN NewsFeed - 31 May 2008
Amgen Reports Positive Data at ASCO from Three Studies of Denosumab in Cancer Patients
Amgen Reports Positive Data at ASCO from Three Studies of Denosumab in Cancer Patients
HSMN NewsFeed - 21 May 2008
Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
HSMN NewsFeed - 14 Nov 2007
FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
HSMN NewsFeed - 1 Aug 2007
Genta and Emisphere Technologies File IND with FDA for Oral Drug to Treat Bone Disease
Genta and Emisphere Technologies File IND with FDA for Oral Drug to Treat Bone Disease
HSMN NewsFeed - 6 Jun 2007
InSightec Receives European CE Mark for ExAblate(R) 2000 Treatment of Pain Caused by Bone Metastases
InSightec Receives European CE Mark for ExAblate(R) 2000 Treatment of Pain Caused by Bone Metastases
HSMN NewsFeed - 22 Mar 2007
Additional Data from Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress
Additional Data from Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress
HSMN NewsFeed - 18 Dec 2006
American Cancer Society Journal Article Reports New Data Regarding Repeated Administration of QUADRAMET(R)
American Cancer Society Journal Article Reports New Data Regarding Repeated Administration of QUADRAMET(R)
HSMN NewsFeed - 19 Sep 2006
Cancer Patients Show Reduced Pain and Lower Analgesic Consumption Following Treatment with QUADRAMET(R)
Cancer Patients Show Reduced Pain and Lower Analgesic Consumption Following Treatment with QUADRAMET(R)
HSMN NewsFeed - 26 Jul 2006
Cytogen Announces Publication of Peer-Reviewed Journal Article on QUADRAMET(R)
Cytogen Announces Publication of Peer-Reviewed Journal Article on QUADRAMET(R)
HSMN NewsFeed - 22 Feb 2006
Investigational Therapy Denosumab Increased Bone Mineral Density with Twice-Yearly Dosing
Investigational Therapy Denosumab Increased Bone Mineral Density with Twice-Yearly Dosing
Additional items found! 59

Members Archive contains
59 additional stories matching:
bone metastases
(Password required)
bone metastases
(Password required)